Report for Q1 2026
Filed with SSE · · 12 pages · Chinese
Chengdu Olymvax Biopharmaceuticals Inc. on 6ix
Earlier from Chengdu Olymvax Biopharmaceuticals
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Requesting the General Meeting to Authorize the Board of Directors to Handle Matters Related to Issuance of Shares to Specific Objects through Summary Procedure
- Preliminary Earnings Estimate for 2025
- Announcement on Shareholding Reduction Plan for Shareholders
- Announcement on Voluntary Disclosure of Obtaining the GMP Compliance Certificate from the Philippines
Later from Chengdu Olymvax Biopharmaceuticals
- Announcement on Expiration of Shareholding Reduction Period and Result of No Share Reduction by Shareholders with over 5% Shares
- Announcement on Release of Pledge of Partial Shares Held by Shareholders with Over 5% Shares
- Announcement on Pledge of Some Shares Held by Shareholder with Over 5% Shares
- Announcement on Tax Payment Remediation
- Announcement on the Implementation of Repurchase and Cancellation of the Class A Restricted Shares Initially Granted under the 2023 Restricted Stock Incentive Plan
Follow Chengdu Olymvax Biopharmaceuticals into a list and get an email when it puts out news.
Follow Chengdu Olymvax Biopharmaceuticals